Loss of MTAP expression is a negative prognostic marker in Ewing sarcoma family of tumors

Ewing sarcoma: a chronicle of molecular pathogenesis

(2016) Sang Kyum Kim et al.   HUMAN PATHOLOGY

Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group

(2016) Thomas Cash et al.   PEDIATRIC BLOOD & CANCER

Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines

(2016) Sarah Franco Vieira de Oliveira et al.   PLoS One

Characterization and Prognostic Significance of Methylthioadenosine Phosphorylase Deficiency in Nasopharyngeal Carcinoma

(2015) Hong-Lin He et al.   MEDICINE

Expression of Methylthioadenosine Phosphorylase (MTAP) in Pilocytic Astrocytomas

(2015) Aline Paixão Becker et al.   PATHOBIOLOGY

Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian Collaborative Study Group for Ewing Sarcoma Family Tumors-EWING1

(2015) Algemir L. Brunetto et al.   PEDIATRIC BLOOD & CANCER

MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients

(2014) C.-Y. Su et al.   EJSO

Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity

(2011) Joseph R. Bertino et al.   CANCER BIOLOGY & THERAPY

Downregulation of methylthioadenosin phosphorylase by homozygous deletion in gastric carcinoma

(2011) Jin Kim et al.   GENES CHROMOSOMES & CANCER

Ethnic and racial differences in patients with Ewing sarcoma

(2010) Jennifer Worch et al.   CANCER

Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry

(2010) Joe Lee et al.   CANCER

Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome

(2009) Muhammad U. Jawad et al.   CANCER

Selective Killing of Tumors Deficient in Methylthioadenosine Phosphorylase: A Novel Strategy

(2009) Martin Lubin et al.   PLoS One